Methodology
How source type, jurisdiction, source date, review date, and confidence level are recorded.
OpenDocumentation
Guides, platform reference, and data methodology.
How to get started with GHMAP, how the platform organizes market-access work, where each audience begins, how source and confidence language is recorded, and what is not published yet.
Before you rely on this
Important notice
GHMAP documentation describes how the platform organizes healthcare market-access intelligence. It does not provide diagnosis, treatment advice, legal advice, regulatory approval, reimbursement guarantees, investment advice, or market-entry guarantees. Do not submit patient data, medical records, passwords, bank information, or confidential contracts through public pages.
Getting Started
Start with the public pages that explain how GHMAP structures market-access work before you open a project.
- Use the sample brief to see how source status, evidence gaps, review needs, and next actions appear in a GHMAP country comparison.
- The resource center covers source-status language, glossary terms, and how to read a brief before you rely on any field.
- When you are ready for a reviewed package, start a project so a human review path can be scoped to your product and target markets.
Platform Overview
GHMAP organizes healthcare market-access questions across countries, products, certifications, and review workflows.
- Public tools and workspace pages keep source status visible so teams can separate verified inputs from placeholders and open questions.
- Country intelligence, certification pathways, readiness checks, and project workflows are designed to support planning — not to replace qualified professionals.
- Public website behavior on ghmap.io stays separate from authenticated workspace behavior on app.ghmap.io.
For Each Audience
GHMAP serves manufacturers, clinicians, distributors, hospitals, investors, and operators with role-specific market-access planning paths.
- Manufacturers
- Doctors & KOLs
- Distributors
- Hospitals
- Investors
- Operators & Consultants
- Manufacturers structure product-country questions, certification context, and launch-readiness needs before committing resources.
- Doctors and KOLs contribute clinical and local-market review context where professional input is required.
- Distributors and importers organize partner-readiness, documentation, and market-entry dependencies.
- Hospitals and clinics evaluate vendor and introduction context with source and review status kept visible.
- Investors and advisors compare evidence gaps, pathway questions, and review needs across target markets.
- Operators and consultants coordinate multi-stakeholder workflows without treating GHMAP as a substitute for specialist advice.
Data & Methodology
Every market-access field should carry source context, confidence language, and a clear review boundary.
- GHMAP methodology distinguishes source type, jurisdiction, source date, review date, and confidence level where those fields are recorded.
- Labels such as Source required, To be verified, Reviewed, Outdated, and Example only are planning signals — not regulatory or reimbursement conclusions.
- Professional review remains required before market-access content is used for business decisions.
API
Coming soonA public developer API is not published yet. Coming soon — do not assume endpoints, authentication schemes, or rate limits.
- GHMAP does not currently publish public API reference documentation or stable endpoint contracts.
- If your team needs machine-readable market-access exports or integrations, describe the use case when you start a project so it can be reviewed against current platform capabilities.
- Until public API docs ship, treat any third-party or speculative endpoint lists as unverified.
Related reading
Where documentation continues
Methodology, trust standards, and the sample brief carry the detail that this reference only summarizes.
Ready to begin?
Start a project to scope product, countries, open questions, and review needs.
Related public pages remain available for methodology, trust, and sample brief context.
Professional review is required before business use.